Publications
amfAR produces a variety of fact sheets, reports, issue briefs, periodicals and infographics. You can download them at the links below or request a hard copy by emailing us at info@amfar.org or writing to amfAR, Public Information Department, 120 Wall Street, 13th Floor, New York, NY 10005-3908.
- About amfAR
- HIV Awareness and Prevention
- HIV/AIDS in the U.S.
- The Global Epidemic
- Treatment Information
- HIV/AIDS in Asia
ABOUT amfAR
- Innovations: The Newsletter of amfAR, The Foundation for AIDS Research (Print and digital, biannual – Sign up here)
- The Broad Benefits of AIDS Research (Booklet, 2019)
- 2022 Annual Report
- 2021 Annual Report
- 2020 Annual Report
- 2019 Annual Report
- 2018 Annual Report
- INSIGHTS: Monthly Updates Sign-Up
HIV AWARENESS AND PREVENTION
- A Dangerous Precedent: Tennessee Rejects Federal Funds for HIV Prevention (2023)
- Facts for Life: What You and the People You Care About Need to Know About HIV/AIDS
- Expanding Access to Pre-Exposure Prophylaxis (PrEP) for Adolescents and Young Adults: Models for Addressing Consent, Confidentiality, and Payment Barriers (Issue brief, 2019)
- Toward an Effective Strategy to Combat HIV, Hepatitis C and the Opioid Epidemic: Recommendations for Policy Makers (Report, 2018)
- Preventing HIV and Hepatitis C Among People Who Inject Drugs: Public Funding for Syringe Services Programs Makes the Difference (Issue brief, 2017)
HIV/AIDS IN THE U.S.
- Context Matters: Health Insurance Coverage Is Fundamental to Ending the HIV Epidemic (2020)
- Context Matters: Ending the HIV Epidemic Among Black Communities (Infographic, 2020)
- Context Matters: Ending the HIV Epidemic Among Latinx (Infographic, 2019)
- Ending the HIV Epidemic Database (Infographic, 2019)
- Title X, the Domestic Gag Rule, and the HIV Response (Issue brief, 2019)
- Long-Acting HIV Treatment and Prevention Are Coming: Preparing for Potential Game Changers (2018)
THE GLOBAL EPIDEMIC
- Structured for Success: Legislative Purpose, Targets, and Focus under PEPFAR vs. International Pandemic Preparedness (2023)
- Structured for Success: Centralized Coordinating Authority under PEPFAR vs. International Pandemic Preparedness (2023)
- Structured for Success: Political Will, Power, and Process in the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) (2022)
- Increasing Trans Inclusion in HIV/AIDS National Strategic Planning: Learning from Community Advocacy in Five Countries (2022)
- A Neglected Population: Transgender Inclusion in National HIV Plans (2021)
- Pepfar COP Update: Key Populations, Size Estimates, and Plans in COP22 (Issue brief, 2022)
- Blinded by Our Own Data—Recency Testing in PREPFAR (Policy Report, 2022)
- PEPFAR in the Age of COVID-19: The Need for Supplemental Funding (Infographic, 2020)
- Violence Crisis Services During Lockdown: An Assessment of Service Availability During COVID-19 Lockdown in South Africa (Issue brief, 2020)
- The Expanded Mexico City Policy: Implications for the Global Fund (Issue brief, 2019)
- Data Watch: Data Accessibility from Global Funders of HIV, TB, and Malaria Programming (Report, 2019)
- How the Global Fund Improves PEPFAR Investments (Infographic, 2019)
- A Global Response to HIV Requires the Global Fund (Infographic, 2019)
- New HIV Testing Strategies in PEPFAR COP19: Rollout and Human Rights Concerns (Issue brief, 2019)
- How Expanded Mexico City Policy Is Disrupting Global HIV Programs (Infographic, 2019)
- The Effect of the Expanded Mexico City Policy on HIV/AIDS Programming: Evidence from the PEPFAR Implementing Partners Survey (Issue brief, 2019)
- Impact of Mexico City Policy on PEPFAR (Issue brief, 2018)
- When Size Matters: How Social Media Can Help Determine Key Population Size (Infographic, 2018)
TREATMENT INFORMATION
- HIV Treatment Clinical Brief: Dolutegravir (2018)
- HIV Treatment Snapshot: Dolutegravir (2017)
- Fact Sheet on WHO Guidelines for the Screening, Care, and Treatment of Persons with Hepatitis C Infection (2016)
- Hepatitis C Treatment Snapshots: Ledipasvir + Sofosbuvir (2016)
- Hepatitis C Treatment Snapshots: Daclatasvir (2016)
HIV/AIDS IN ASIA
- Hepatitis B: A Hidden Public Health Emergency in the Asia-Pacific (August 2023)
- HIV Care Continuum & Beyond: A New Era for Asia (December 2022)
- Community-led Monitoring in Country Proposals for the Global Fund 2023–2025 Funding Cycle (NFM4) (November 2022)
- TREAT Asia Calls for Expanded Access to Pediatric Dolutegravir (2022)
- Analysis of Community Treatment Observatory Data for HIV and Hepatitis C Virus Services in India and Indonesia (2022)
- Fact Sheet: WHO Guidelines for the Screening, Care, and Treatment of Persons with Hepatitis C Infection (Available in English, Mandarin, Indonesia Bahasa, Malay, Thai, and Vietnamese)
- Resources to Support Transition of Adolescents from Pediatric to Adult HIV Care
- PrEP Acceptability Among Female Sex Workers in Thailand: Key Research Findings (2017)